Grifols, Kedrion S.p.A., Talecris deal

Grifols and Talecris said they signed a Consent Agreement with the U.S. Federal Trade Commission (FTC) regarding Grifols' previously announced plan to acquire Talecris in a cash and stock deal that the companies said values Talecris at $26.16 per share, or about $3.4 billion (see BioCentury, June 14, 2010). ...